Karolinska Institutet - Sweden

Karolinska Institutet (KI), is Sweden’s largest medical university with more than 600 research units comprising some 2800 research staff and about 2500 postgraduate students.The Division of International Health Research (IHCAR) has since its establishment in 1984 become the most active and well-recognized setting for international health research in Sweden. Some 30 researchers and 45 research students from 15 countries are divided into several research groups with competitively acquired independently financed projects. IHCAR’s professional diversity enables cross-cultural and interdisciplinary research on poverty-related health problems in low-income countries. IHCAR’s research training model, to be employed for capacity building also in the current project, enables foreign MPH or PhD students to combine research or work at home with free-of-charge training periods at KI. IHCAR has extensive experience of designing, planning and evaluating development aid projects in the health sector, providing policy recommendations for partners such as the WHO, UNDP, World bank, UNICEF and the EC, and, has been an institutional consultant to Sida for a decade.
Qualitative and quantitative research methods are combined for studies in the areas of HIV/AIDS, health systems, health policy, drug policy, sexual reproductive health, gender aspects of access to care and health seeking behaviour for TB, maternal mortality, child care especially IMCI, evaluation of home-based treatment for malaria and graphic display of global health data over time “The World Health Chart”, a free software invented by IHCAR professor Hans Rosling http://www.gapminder.org/.
Read more at www.ki.se


The ARVMAC team

Scientific Coordinator:
Anna Mia EkströmAnna Mia Ekström (MD, MPH, PhD), infectious disease/HIV doctor with an MPH (1995) from Harvard University in quantitative methods/study design, and a PhD in medical epidemiology (2000). Anna Mia leads a research group focussing on HIV epidemiology, health system constraints for scaling of access to antiretroviral treatment, HIV drug resistance development in high-prevalence settings, sexual risk behaviour and PMTCT with HIV research projects in Sweden Tanzania, Uganda, Burkina Faso, Kenya, and South Africa. Anna Mia Ekström also runs KI’s largest non-core course on HIV/AIDS and has worked as a short-term consultant for SIDA and the WHO on health policy, health interventions for poverty reduction from a Burden of Disease perspective in SSA and gender aspects of HIV in Eastern Europe. Since 2006 Dr Ekström is the scientific coordinator for ARVMAC. anna.mia.ekstrom@ki.se

Financial Coordinator:
Janet Jeppsson, MSc in International Business and Economics. Financial administrator at IHCAR and Grants Office, Karolinska Institutet. Previous experience: Programme officer at UNDP, Costa Rica; International Admin officer at the Civil Emergency Agency, Sweden. janet.jeppsson@ki.se


Anna ThorsonAnna Thorson (MD, DTM&H, MPH, PhD), infectious disease doctor, diploma in tropical medicine from Paris who did her PhD (2003) on equity and gender aspects of case detection of TB, a series of studies set in the Fila Bavi DSS in Vietnam. Coordinator of a collaborative research programme on Health systems research between Hanoi Medical University, Vietnam, Umeå University and KI. Worked as a short-term consultant for the WHO on gender aspects of HIV and TB in Eastern Europe and Central Asia. Dr Thorson is the co-leader of the IHCAR research group on HIV/AIDS with projects and research students in Vietnam, Tanzania, Uganda, and Burkina Faso and Kenya. Since 2006, Dr Thorson is one of ARVMAC’s 7 workpackage leaders responsible for WP7 on Equity and Access to ART. anna.thorson@ki.se

Jaran EriksenJaran Eriksen (MD, PhD), received his PhD in international health in 2006. Jaran’s research area spans broadly from molecular markers, drug treatment and case management of patients to policy adoption at society level. He has spent two years doing research in Morogoro and Pwani regions in Tanzania and has worked with the SAREC funded malaria case management project (a collaboration between KI and Muhimbili University College of Health Sciences (MUCHS) in Tanzania),the EC-funded MAMOP project (collaboration between Heidelberg University, Germany; CRSN, Burkina Faso; KI, Sweden and MUCHS, Tanzania) and is currently involved in HIV projects in Sweden, Uganda, Burkina Faso and Tanzania. jaran.eriksen@ki.se

Göran ThomsonProfessor Göran Tomson (MD, PhD), paediatrician, professor in international health systems research, with experience from many INCO-DEV projects in Africa and Asia including POVILL and MAMOP (Burkina Faso & Tanzania), coordinating SAREC Malaria project in Tanzania, part of the KI- Makerere health system project in Uganda, and a member of WHO expert panel on drug policy and management, WHO Task force on Health Systems Research and the International network on rational use of drugs. Since 2006, Dr Tomson is one of the senior researchers working on the ARVMAC project.

KI PHD students in ARVMAC

Abela AgnarssonAbela Agnarson (MSc), has a master of Medical Sciences in Molecular Cell Biology. Abela worked with the Swedish CDC before starting her post-graduate studies at IHCAR. Her thesis is within the ARVMAC project, focusing on where the access and uptake of HIV/AIDS care in relation to antiretroviral treatment (ART) scale-up in three demographic surveillance systems (DSSs) in Tanzania (Rufiji), Uganda (Iganga-Mayuge) and Burkina Faso (Nouna) DSS. abela.agnarson@ki.se

Elin LarssonElin Larsson (MSc Pharm), a pharmacist with experience from different types of fieldwork in Uganda related to HIV and antiretroviral treatment. Her thesis is within the ARVMAC project, focusing on pregnant women’s access to HIV testing and ARVs for prevention of mother to child transmission (PMTCT) of HIV in three demographic surveillance system (DSSs) in Tanzania (Rufiji), Uganda (Iganga-Mayuge) and Burkina Faso (Nouna) DSS. elin.larsson@ki.se


Max PetzoldMax Petzold (PhD), biostatistician working with longitudinal follow-ups and evaluation of interventions, specializing on demographic surveillance sites (DSS) and low-income settings. Max has experience from analyses of HIV/AIDS, malaria, dengue and leishmaniasis.  max@nhv.se


Karolinska Institutet, Sweden
Karolinska Institutet

Makerere University, Uganda
Makerere University

Swiss Tropical Institute
Tropical Institute

The Ifakara Health Institute, Tanzania
The Ifakara Health Research and Development Center - Tanzania

Insititute of Tropical Medicine Antwerp, Belgium
Prince Leopold Insititute of Tropical Medecine

University of Heidelberg, Germany
University of Heidelberg

Centre de Recherche en Santé de Nouna, Burkina Faso
Centre de Recherche en Santé de Nouna Demographic Surveillance System Site